References
- Epelbaum R., Faraggi D., Denmarie Y., et al. Survival of diffuse large cell lymphoma. Cancer 1990; 66: 1124–9
- Ho A. D., Del Valle F., Rückie H., et al. Mitoxantrone and high dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma. Cancer 1989; 64: 1388–92
- Amlot P. L., Adinolfi M. Serum beta 2 microglobulin and its prognostic value in lymphoma. Eur. J. Cancer 1979; 15: 791–7
- Coiffer B., Shipp M. A., Cabanillas F., Crowther D., Armitage J. O., Canellos G. P. Report of the first workshop on prognostic factors in large-cell lymphoma. Ann. Oncol. 1991; 2(Suppl. 2)213–7
- Swan F., Velasquez W. S., Tucker S., et al. A new serologic staging system for large-cell lymphoma based on initial beta 2 microglobulin and lactate dehydrogenase levels. J. Clin. Oncol. 1989; 7: 1518–27
- Litam P., Swan F., Cabanillas F., et al. Prognostic value of serum beta 2 microglobulin in low-grade lymphomas. Ann. Intern. Med. 1991; 114: 855–60
- Avilés A., Zepeda G., Dias-Maqueo J. C., et al. Beta 2 microglobulin level as indicator of prognosis in diffuse large cell lymphoma. Leuk. and Lymph. 1992; 7: 135–138
- The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute Study sponsored study of classification of non-Hodgkin's lymphoma. Cancer 1982; 49: 2111–35
- Avilés A., Díaz-Maqueo J. C., Torras V., Rodriguez L., López V. D. Linfomas no Hodgkinianos. Resultados de la quimioterapia alterna frente a la quimioterapia secuencial. Sangre. 1990; 35: 245–9
- Avilés A., Huerta J., Zepeda G., et al. m-BACOD en el tratamiento de linfomas malignos. Rev. Invest. Clin. 1990; 42: 271–6
- Kaplan E. L., Meier P. Non parametric estimations from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–81
- Conover W. J. Practical non-parametric statistics. Wiley, New York, NY 1980
- Vose J. M., Armitage J. O., Bierman P. J., et al. Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation. Am. J. Med. 1989; 87: 285–8
- Cotter F. E., Price C., Young B. D., Lister T. A. Minimal residual disease in leukaemia and lymphoma. Ann. Oncol. 1990; 1: 67–70
- Weeks J. C., Yeap B. Y., Canellos G. P., Shipp M. A. Value of follow-up procedures in patients with large-cell lymphoma who achieved complete remission. J. Clin. Oncol. 1991; 9: 1196–1203